Device / Technology News

RSS

Universal tumor testing superior to selective strategy in identifying Lynch syndrome among CRC patients

In a comparison of strategies to identify individuals with Lynch syndrome, the most common form of hereditary colorectal cancer (CRC), caused by mutations in certain genes (DNA mismatch repair [MMR] genes), universal tumor MMR testing among certain CRC patients had a greater sensitivity for the identification of Lynch syndrome compared with multiple alternative strategies, although the diagnostic improvement was modest, according to a study in the October 17 issue of JAMA.

17 Oct 2012

Extradural brain stimulation safe and effective for patients with Parkinson's

Electrical stimulation using extradural electrodes—placed underneath the skull but not implanted in the brain—is a safe approach with meaningful benefits for patients with Parkinson's disease, reports the October issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

17 Oct 2012

GENNET, BGI enter collaborative agreement for non-invasive fetal trisomy test

BGI, the world's largest genomics organization, and GENNET, a center for genetics, fetal medicine and assisted reproduction, jointly announced that they have entered a collaborative agreement on non-invasive fetal trisomy (NIFTY) test with the aim to significantly improve reproductive health in Czech and Slovak Republic. Th

17 Oct 2012

iLarynx app effective at simulating fiberoptic bronchoscopy

A study presented during the ANESTHESIOLOGY 2012 annual meeting has shown that an iPhone application called iLarynx was so effective at simulating fiberoptic bronchoscopy that when app-trained students eventually used a real bronchoscope on a manikin, they completed the procedure in less than half the time than students exposed only to anatomy photos.

17 Oct 2012

Positive results from PROLOR's Rpeg preclinical toxicology study

PROLOR Biotech, Inc. today announced positive results from a preclinical toxicology study designed to assess the safety and tolerability of PROLOR's proprietary long-acting reversible-pegylation technology.

17 Oct 2012

Philips to showcase advancements that allow patients to sleep and breathe easier at Medtrade 2012

Philips Respironics, a unit of Royal Philips Electronics, today at Medtrade 2012 showcases advancements that allow patients to sleep and breathe easier, demonstrating its commitment to improving the quality of life of those who suffer from chronic sleep and respiratory conditions.

17 Oct 2012

Transvaginal ultrasound effective in treating early-stage endometrial cancer

A common birth control device is effective in treating early-stage endometrial cancer in morbidly obese and high-risk surgery patients, said Georgia Health Sciences University Cancer Center researchers, and could lead to a cost-effective treatment for all women with this cancer type.

17 Oct 2012

USPTO issues patent to Positron’s solid state sensors

Positron Corporation announced today that the United States Patent and Trademark Office (USPTO) has awarded the Company a patent (U.S. No. 8,269,181) for its original semiconductor detector used in high precision measuring of coordinates and detection of ionization particles.

17 Oct 2012

Thermo Fisher Scientific introduces MYECL Imager instrument

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific MYECL Imager, an easy-to-use imaging instrument that delivers one-touch image capture and analysis of protein and nucleic acid gels and Western blots.

From Thermo Fisher Scientific Inc. 17 Oct 2012

FDA approves Hologic’s APTIMA HPV 16 18/45 Genotype Assay for use on TIGRIS system

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's APTIMA HPV 16 18/45 Genotype Assay for use on its TIGRIS instrument system.

From Hologic, Inc. 16 Oct 2012

First analysis of IASLC malignant pleural mesothelioma database

The International Mesothelioma Interest Group (IMIG) staging system has been widely used, however, widespread concerns exist about the validity of the current malignant pleural mesothelioma (MPM) staging system.

16 Oct 2012

Transcranial magnetic stimulation can benefit patients with depression, debilitating tinnitus

Three patients who have suffered periodic major depression throughout their adult lives told an audience attending a Loyola Grand Rounds presentation how their lives have been transformed by a new magnetic therapy.

16 Oct 2012

Computerized checklist helps physicians to prevent dangerous venous thromboembolisms or PE

A computerized checklist system designed to help physicians identify and use the best methods of preventing potentially deadly blood clots in hospitalized trauma patients dramatically reduced the number of these dangerous venous thromboembolisms (VTEs), new Johns Hopkins research suggests.

16 Oct 2012

Drug-eluting balloon procedure can effectively treat peripheral artery disease

Use of balloon angioplasty and placement of stents to widen clogged arteries have become standard medical procedure. Further advancing this treatment, drug-eluting devices are now delivering medication directly to the site where it can be most effective. While this technique has met with success in coronary arteries, its use in peripheral arteries is still under study.

16 Oct 2012

Hepatitis C rapid and point of care tests highly accurate and reliable

Timely screening and diagnosis is critical to the success of new treatments and ultimately to the survival of hepatitis C patients. A new study led by the Research Institute of the McGill University Health Centre (RI MUHC) is the first to show that hepatitis C rapid and point of care tests with a quick turnaround time are highly accurate and reliable as conventional first-line laboratory tests.

16 Oct 2012

Radioactive gold nanoparticle treatment safe and effective in dogs with prostate cancer

Currently, large doses of chemotherapy are required when treating certain forms of cancer, resulting in toxic side effects. The chemicals enter the body and work to destroy or shrink the tumor, but also harm vital organs and drastically affect bodily functions. Now, scientists at the University of Missouri have proven that a new form of prostate cancer treatment that uses radioactive gold nanoparticles, and was developed at MU, is safe to use in dogs.

16 Oct 2012

VeriStrat identifies NSCLC patients likely to respond to erlotinib

A study, published in the November 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, showed the plasma test VeriStrat can predict response but not survival benefit from erlotinib. The study was conducted on a subset of patients enrolled in the NCIC Clinical Trials Group, BR.21 phase III trial of erlotinib versus placebo in previously treated advanced non-small cell lung cancer patients.

16 Oct 2012

Computer-delivered interventions do not effectively curb problematic college drinking

Computer-delivered and face-to-face interventions both can help curb problematic college drinking for a little while, but only in-person encounters produce results that last beyond a few months, according to a new analysis of the techniques schools use to counsel students on alcohol consumption.

16 Oct 2012

NIH to accelerate development and application of single cell analysis across various fields

The National Institutes of Health plans to invest more than $90 million over five years, contingent upon the availability of funds, to accelerate the development and application of single cell analysis across a variety of fields.

16 Oct 2012

Helmet use may decrease cycling mortality from fatal head injuries

Cyclists who died of a head injury were three times as likely to not be wearing a helmet compared with those who died of other injuries, according to a study in CMAJ.

16 Oct 2012

Device / Technology News

Universal tumor testing superior to selective strategy in identifying Lynch syndrome among CRC patients

Extradural brain stimulation safe and effective for patients with Parkinson's

GENNET, BGI enter collaborative agreement for non-invasive fetal trisomy test

iLarynx app effective at simulating fiberoptic bronchoscopy

Positive results from PROLOR's Rpeg preclinical toxicology study

Philips to showcase advancements that allow patients to sleep and breathe easier at Medtrade 2012

Transvaginal ultrasound effective in treating early-stage endometrial cancer

USPTO issues patent to Positron’s solid state sensors

Thermo Fisher Scientific introduces MYECL Imager instrument

FDA approves Hologic’s APTIMA HPV 16 18/45 Genotype Assay for use on TIGRIS system

First analysis of IASLC malignant pleural mesothelioma database

Transcranial magnetic stimulation can benefit patients with depression, debilitating tinnitus

Computerized checklist helps physicians to prevent dangerous venous thromboembolisms or PE

Drug-eluting balloon procedure can effectively treat peripheral artery disease

Hepatitis C rapid and point of care tests highly accurate and reliable

Radioactive gold nanoparticle treatment safe and effective in dogs with prostate cancer

VeriStrat identifies NSCLC patients likely to respond to erlotinib

Computer-delivered interventions do not effectively curb problematic college drinking

NIH to accelerate development and application of single cell analysis across various fields

Helmet use may decrease cycling mortality from fatal head injuries

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News